Napp Pharmaceuticals Limited, part of the global healthcare company Mundipharma, is dedicated to delivering innovative treatments to patients across various regions including Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. The company focuses on areas such as Pain Management, Infectious Disease, and Consumer Healthcare, as well as other severe and debilitating disease areas. With a commitment to integrity and patient-centricity, Napp Pharmaceuticals strives to build long-term relationships with healthcare professionals and key stakeholders, ensuring that their products align with local clinical and financial goals to maximize patient outcomes.